The Cancer Research Program at Fondation de France is dedicated to addressing one of the most critical challenges in oncology: understanding and overcoming treatment resistance. Despite significant advancements in cancer prevention, screening, treatment, and management, too many patients still experience treatment failures. The program focuses on unraveling why certain therapeutic protocols, proven effective for some cancers and patients, fail for others. By investigating the mechanisms of cancer resistance, Fondation de France aims to develop strategies to neutralize these barriers, ultimately improving patient outcomes and advancing the global fight against cancer.
Fondation de France funds a variety of projects to advance cancer research, focusing on:
The Oncology Treatment Resistance program is a key initiative, supporting around 15 projects annually with a total budget of approximately two million euros.
Through Friends of Fondation de France, US donors can contribute to the vital work of the Cancer Research Program. Donations help fund cutting-edge research to understand cancer better and develop more effective treatments as well as initiatives to improve cancer prevention, screening, and management. Supporting these programs enables donors to play a crucial role in the global fight against cancer, fostering breakthroughs that can save lives and improve the quality of care for patients worldwide.
As we approach the celebration of the 250th anniversary of the United States, and of the special friendship between our two nations, we reflect on
Gustave Roussy is one of the world’s foremost cancer research hospitals and comprehensive cancer centers, working at the cutting edge of therapy development while treating
From the rise of chronic diseases to the health impacts of climate change, societies in France and around the world face unprecedented health challenges. Millions